Beta83% was sold under disclosed trading plans, 17% with no plan disclosed. The largest seller, Roger Susi (CEO, President, Chairman, Director), sold $16.2M.Share-of-stake figures for this company are being verified and will be added when that check is finished. Why
A share of stake is shown for 0 of the 5 officers and directors who sold. 7 are left out Disclosed company stock is not an insider's whole wealth.i
Left out: Roger Susi, James Hawkins, Monty Allen, John Glenn, Hilda Scharen-Guivel, Jeff Chiprin and Joe Kiani (share of stake is being verified).
Officers and directors, past 12 months. Their share of stake is being verified and is not shown yet; amounts and trading plans are below.
Officers and directors, Oct 2025 to Oct 2026. Each sale is counted once: under a disclosed plan, else to cover taxes, else no plan disclosed.
No officer or director trades were reported for the past 30 days. The most recent before that:
| Who | Shares | Price | % of total stake | Total stake after | Trade date | Filed |
|---|---|---|---|---|---|---|
| Monty Allen Director | 1,419 | $86.41 | n/a | n/a | Sep 3, 2026 | Sep 8, 2026 |
Yes. Roger Susi sold 175K shares ($16.2M) in the past 12 months, all of it under a trading plan disclosed in the filings.
Filings rarely give a reason, and we don't guess at one. What they show is how the sales were made: 83% of sales by value ran under 10b5-1 trading plans disclosed in the filings and 17% had no disclosed plan. A trading plan schedules sales in advance.
No. Officers and directors reported no purchases in the past 12 months.
| Who sold | Amount | % of holdings | Trading plan |
|---|---|---|---|
| Roger Susi CEO, President, Chairman, Director | $16.2M 175K shares | Not confirmedshare of stake is being verified. Why | Disclosed plan |
| John Glenn CFO | $2.4M 26K shares | Not confirmedshare of stake is being verified. Why | No plan disclosed |
| James Hawkins Director | $555K 6K shares | Not confirmedshare of stake is being verified. Why | No plan disclosed |
| Hilda Scharen-Guivel Director | $285K 3K shares | Not confirmedshare of stake is being verified. Why | No plan disclosed |
| Monty Allen Director | $223K 2.4K shares | Not confirmedshare of stake is being verified. Why | No plan disclosed |
Vested shares across all share classes, held directly and through trusts, LLCs and family members, as reported on SEC Forms 3, 4 and 5. Unvested awards and options are never counted as owned shares.
| Insider | Held Oct 16, 2025 | Sold | Held Oct 16, 2026 | Still held | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Roger Susi!Holdings and share of stake are being verified. Share-of-stake figures and holdings for this company are held back while they are verified. Sales and other transactions for Roger Susi are complete. CEO, President, Chairman, Director | n/a | −175K | n/a | n/a | ||||||||||||
Vesting, gifts, unvested awards and holding lines for Roger SusiHoldings and share of stake are being verified. Sales, proceeds, plan and tax status and dates for Roger Susi are complete; balances and unit counts will be added when the check is finished. 0gifted (net of own trusts) | ||||||||||||||||
James Hawkins!Holdings and share of stake are being verified. Share-of-stake figures and holdings for this company are held back while they are verified. Sales and other transactions for James Hawkins are complete. Director | n/a | −6K | n/a | n/a | ||||||||||||
Vesting, gifts, unvested awards and holding lines for James HawkinsHoldings and share of stake are being verified. Sales, proceeds, plan and tax status and dates for James Hawkins are complete; balances and unit counts will be added when the check is finished. 0gifted (net of own trusts) Stock options (not counted as shares):
Estimate: options held × ($86.35 − strike price), using the most recent insider trade price on Form 4 (Sep 3, 2026), not a market close. | ||||||||||||||||
Monty Allen!Holdings and share of stake are being verified. Share-of-stake figures and holdings for this company are held back while they are verified. Sales and other transactions for Monty Allen are complete. Director | n/a | −2.4K | n/a | n/a | ||||||||||||
Vesting, gifts, unvested awards and holding lines for Monty AllenHoldings and share of stake are being verified. Sales, proceeds, plan and tax status and dates for Monty Allen are complete; balances and unit counts will be added when the check is finished. 0gifted (net of own trusts) | ||||||||||||||||
John Glenn!Holdings and share of stake are being verified. Share-of-stake figures and holdings for this company are held back while they are verified. Sales and other transactions for John Glenn are complete. CFO | n/a | −26K | n/a | n/a | ||||||||||||
Vesting, gifts, unvested awards and holding lines for John GlennHoldings and share of stake are being verified. Sales, proceeds, plan and tax status and dates for John Glenn are complete; balances and unit counts will be added when the check is finished. 0gifted (net of own trusts) −15Kwithheld by the company for taxes | ||||||||||||||||
Hilda Scharen-Guivel!Holdings and share of stake are being verified. Share-of-stake figures and holdings for this company are held back while they are verified. Sales and other transactions for Hilda Scharen-Guivel are complete. Director | n/a | −3K | n/a | n/a | ||||||||||||
Vesting, gifts, unvested awards and holding lines for Hilda Scharen-GuivelHoldings and share of stake are being verified. Sales, proceeds, plan and tax status and dates for Hilda Scharen-Guivel are complete; balances and unit counts will be added when the check is finished. 0gifted (net of own trusts) | ||||||||||||||||
Jeff Chiprin!Holdings and share of stake are being verified. Share-of-stake figures and holdings for this company are held back while they are verified. Sales and other transactions for Jeff Chiprin are complete. Chief Commercial Officer | n/a | 0 | n/a | n/a | ||||||||||||
Vesting, gifts, unvested awards and holding lines for Jeff ChiprinHoldings and share of stake are being verified. Sales, proceeds, plan and tax status and dates for Jeff Chiprin are complete; balances and unit counts will be added when the check is finished. 0gifted (net of own trusts) −309withheld by the company for taxes | ||||||||||||||||
Joe Kiani!Holdings and share of stake are being verified. Share-of-stake figures and holdings for this company are held back while they are verified. Sales and other transactions for Joe Kiani are complete. Director | n/a | 0 | n/a | n/a | ||||||||||||
Vesting, gifts, unvested awards and holding lines for Joe KianiHoldings and share of stake are being verified. Sales, proceeds, plan and tax status and dates for Joe Kiani are complete; balances and unit counts will be added when the check is finished. 0gifted (net of own trusts) | ||||||||||||||||
Holdings and share of stake for Iradimed Corp are being verified, so no balances, unit counts or percentages are shown. Sales, proceeds, plan and tax status, titles and dates come straight from individual filings.
Officer and director open-market sales: $19.6M across 212,070 shares. Plan status and stated purpose are separate questions, and a sale can have both.
The lighter segment is sales with no plan disclosed in the filing ($3.4M), including tax-related sales outside a plan.
Sales with no 10b5-1 plan and no tax reference in the filing. $2.4M of it is John Glenn. No plan disclosed is a statement about the filing, not about why the sale happened. Largest such sale: John Glenn, Dec 11, 2025
14,992 shares ($1.4M) were withheld by the company for taxes, which isn't a market sale.
| Seller | Shares sold | Proceeds | Under a disclosed plan | Share of total | Sales dates |
|---|---|---|---|---|---|
| Roger Susi CEO, President, Chairman, Director | 175K | $16.2M | 100% | 83% | Oct 21, 2025 to Jun 1, 2026 |
| John Glenn CFO | 26K | $2.4M | 0% | 12% | Nov 10, 2025 to Dec 11, 2025 |
| James Hawkins Director | 6K | $555K | 0% | 3% | Nov 20, 2025 to Dec 9, 2025 |
| Hilda Scharen-Guivel Director | 3K | $285K | 0% | 1% | Jun 4, 2026 to Jun 4, 2026 |
| Monty Allen Director | 2.4K | $223K | 0% | 1% | Feb 13, 2026 to Sep 3, 2026 |
| Month | Sale proceeds | Disclosed plan | To cover taxes | No plan disclosed |
|---|---|---|---|---|
| Oct 2025 | $763K | $763K | $0 | $0 |
| Nov 2025 | $2.9M | $1.7M | $0 | $1.2M |
| Dec 2025 | $4.1M | $2.4M | $0 | $1.7M |
| Jan 2026 | $2.0M | $2.0M | $0 | $0 |
| Feb 2026 | $100K | $0 | $0 | $100K |
| Mar 2026 | $3.7M | $3.7M | $0 | $0 |
| Apr 2026 | $2.8M | $2.8M | $0 | $0 |
| May 2026 | $2.6M | $2.6M | $0 | $0 |
| Jun 2026 | $512K | $227K | $0 | $285K |
| Jul 2026 | $0 | $0 | $0 | $0 |
| Aug 2026 | $0 | $0 | $0 | $0 |
| Sep 2026 | $123K | $0 | $0 | $123K |
| Oct 2026 | $0 | $0 | $0 | $0 |
In line with the past 5 years. 5 insiders sold; the average is 4 a year.
| 12 months ending | Shares sold | Insiders who sold | Proceeds |
|---|---|---|---|
| Oct 16, 2026 Latest 12 months | 212K | 5 | $19.6M |
| Oct 16, 2025 1 year earlier | 31K | 4 | $2.1M |
| Oct 16, 2024 2 years earlier | 130K | 4 | $5.5M |
| Oct 17, 2023 3 years earlier | 369K | 3 | $16.0M |
| Oct 17, 2022 4 years earlier | 446K | 5 | $19.6M |
| Oct 17, 2021 5 years earlier | 144K | 4 | $4.8M |
Open-market sales (Form 4 code S) by people who were officers or directors, in split-adjusted shares. Earlier years include people who have since left. A sale that an outside holder also reports (a family trust, a fund) is counted with outside holders in every year. Shares, not dollars, are compared, so a change in the stock price doesn't look like a change in selling. Years the filings don't fully cover are shown but left out of the average.
Holdings and share of stake are being verified. Balances, unit counts and every share-of-stake figure for Iradimed Corp are held back until that check is finished. Sales, proceeds, plan and tax status, titles and dates come straight from individual filings and are complete.
External context: we only cite outside events when a documented connection exists. None is shown for this period.
All 487 Forms 3, 4 and 5 on record for Iradimed Corp (SEC CIK 1325618), filed from Jul 15, 2014 to Sep 25, 2026; 51 of them were filed in the 12 months this page covers, retrieved from SEC EDGAR on Oct 16, 2026. Prices are the ones reported in each filing, often weighted averages.
Holdings. Each holding line (a share class plus an owner, such as a trust or LLC) carries its last reported balance forward. Entities first reported during the period start at zero, so transfers between an insider's own trusts don't count as selling. Lines not reported for three years or more are listed separately and left out of totals.
Sales. A sale counts as under a 10b5-1 plan if its footnote cites one or the filing's Rule 10b5-1 box is checked, and as tax-related if its footnote cites tax obligations or sell-to-cover. Shares withheld by the company for taxes are listed separately. Sales with neither attribute are labeled "no plan disclosed".
| Name | Last filed | Last reported balance |
|---|---|---|
| Anthony Vuoto | Dec 13, 2024 | 17,181 shares, last reported balance as of Dec 7, 2024 |
| Christopher Scott | Feb 11, 2022 | 13,710 shares, last reported balance as of Feb 11, 2022 |
| Louis Waldman | Jul 27, 2020 | 38,901 shares, last reported balance as of Jul 24, 2020 |
| Leslie McDonnell | Jun 2, 2020 | 121,333 shares, last reported balance as of May 28, 2020 |
| Brent Johnson | Apr 14, 2020 | 3,663 shares, last reported balance as of Apr 10, 2020 |
| Steven Nardi | Feb 24, 2020 | No balance on record |
| John McCreery | Jan 8, 2020 | 43,315 shares, last reported balance as of Jan 6, 2020 |
| Francis Casey | Jan 3, 2020 | 53,474 shares, last reported balance as of Dec 31, 2019 |
| Jonathan Kennedy | Jun 19, 2019 | 27,386 shares, last reported balance as of Jun 14, 2019 |
| Serge Novovich | Feb 22, 2016 | 244,636 shares, last reported balance as of Feb 19, 2016 |
Spotted something wrong on this page? Report an error. We check every report against the SEC filing and list what we fix in the corrections log.